KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Average (2020 - 2025)

Organon has reported Equity Average over the past 6 years, most recently at $829.0 million for Q4 2025.

  • Quarterly results put Equity Average at $829.0 million for Q4 2025, up 71.81% from a year ago — trailing twelve months through Dec 2025 was $829.0 million (up 71.81% YoY), and the annual figure for FY2025 was $612.0 million, up 204.48%.
  • Equity Average for Q4 2025 was $829.0 million at Organon, up from $819.5 million in the prior quarter.
  • Over the last five years, Equity Average for OGN hit a ceiling of $5.1 billion in Q1 2021 and a floor of -$1.8 billion in Q3 2021.
  • Median Equity Average over the past 5 years was -$170.2 million (2023), compared with a mean of -$8.8 million.
  • Biggest five-year swings in Equity Average: tumbled 185.62% in 2022 and later surged 4709.09% in 2025.
  • Organon's Equity Average stood at -$1.6 billion in 2021, then soared by 37.36% to -$979.0 million in 2022, then skyrocketed by 66.34% to -$329.5 million in 2023, then soared by 246.43% to $482.5 million in 2024, then soared by 71.81% to $829.0 million in 2025.
  • The last three reported values for Equity Average were $829.0 million (Q4 2025), $819.5 million (Q3 2025), and $637.5 million (Q2 2025) per Business Quant data.